Pazopanib

Pazopanib Reactions 1680, p275 - 2 Dec 2017 Malaise and aspartate aminotransferase elevation: case report An adult man in his 20’s [exact age not stated] developed malaise and aspartate aminotransferase elevation during treatment with pazopanib [time to reaction onsets and outcomes not stated]. The man presented in March 2016 at the age of 23 years with a tongue swelling and was diagnosed with alveolar soft part sarcoma in May 2016. He underwent a complete excision of the mass in June. In September, he developed a recurrence of the alveolar soft part sarcoma and was started on combination therapy with doxorubicin and ifosfamide. However, the mass continued to grow rapidly and the regimen was withheld, and he was started on monotherapy with oral pazopanib 800 mg/day in October. Subsequently, he developed grade 1 malaise and aspartate aminotransferase elevation of 56 U/L. Author comment: "Pazopanib was well tolerated and the patient experienced no severe adverse events other than Grade 1 malaise, aspartate aminotransferase elevation (56 U/l) according to the Common Terminology Criteria for Adverse Events". Yoshihiro T, et al. Lingual alveolar soft part sarcoma responsive to pazopanib: A case report. Medicine 96: e8470, No. 44, Nov 2017. Available from: URL: http:// doi.org/10.1097/MD.0000000000008470 - Japan 803285342 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Pazopanib

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/pazopanib-zokVeEHiW0
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39206-7
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial